IP Library Granted Patent US 12,150,700
Granted Patent B2
US 12,150,700 · App. 18/330,177 · Granted Nov 26, 2024

Cardiac pulsed field ablation

Inventors: Mark Stewart (Lino Lakes, MN); Steven J. Fraasch (Maple Grove, MN)
Assignee: Medtronic, Inc.
A61B18/1492A61B18/1206A61N1/327A61B2018/00351A61B2018/00577A61B2018/00613A61B2018/0075A61B2018/00761A61B2018/00767A61B2018/00839A61B2018/126A61B2018/1407
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,150,700
App. No.
18/330,177
Granted
Nov 26, 2024
Kind
B2
Abstract

A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between Oμs and 5 μs, an inter-pulse delay of at least 5 μs, and a pulse width of 5 μs.

Claims (27)

1. A medical device comprising:

a generator in electrical communication with a plurality of electrodes, wherein:

the generator is configured to deliver a pulse train of energy having a predetermined frequency and including a plurality of pulses, each pulse having a pulse width of between 1 μs and 5 μs;

the plurality of pulses includes a sequence of alternating positive pulses and negative pulses with an inter-phase delay after each positive pulse and before a subsequent negative pulse and with an inter-pulse delay after each negative pulse and before a subsequent positive pulse; and

the inter-phase delay is less than the inter-pulse delay.

2. The medical device of claim 1 , wherein the pulse width of each positive pulse is symmetrical to the pulse width of each negative pulse.

3. The medical device of claim 1 , wherein the generator includes an electrical current generator and is configured to control a voltage of the plurality of pulses.

4. The medical device of claim 3 , wherein the voltage of the plurality of pulses is between 300 V and 4,000 V.

5. The medical device of claim 1 , wherein the inter-pulse delay is at least 5 μs.

6. The medical device of claim 1 , wherein the inter-phase delay is between 0 μs and 4 μs.

7. The medical device of claim 1 , wherein the pulse train of energy include biphasic pulses.

8. The medical device of claim 1 , wherein the inter-phase delay, the inter-pulse delay, and the pulse width are constant over the duration of the pulse train of energy.

9. The medical device of claim 1 , wherein the pulse train of energy includes at least 20 pulses.

10. The medical device of claim 1 , wherein the generator is configured to deliver a plurality of pulse trains of energy at a treatment site.

11. The medical device of claim 1 , wherein the pulse train of energy is configured to produce efficacious lesions in cardiac tissue.

12. A method of ablating tissue comprising:

delivering a pulse train of energy having a predetermined frequency to tissue, the pulse train including a plurality of pulses, each pulse having a pulse width of between 1 μs and 5 μs,

the plurality of pulses including a sequence of alternating positive pulses and negative pulses with an inter-phase delay after each positive pulse and before a subsequent negative pulse and with an inter-pulse delay after each negative pulse and before a subsequent positive pulse,

the inter-phase delay being less than the inter-pulse delay.

13. The method of claim 12 , wherein the pulse width of each positive pulse is symmetrical to the pulse width of each negative pulse.

14. The method of claim 12 , wherein the plurality of pulse have a plurality of voltage amplitudes.

15. The method of claim 12 , wherein the voltage of the plurality of pulses is between 300 V and 4,000 V.

16. The method of claim 12 , wherein the inter-pulse delay is at least 5 μs.

17. The method of claim 12 , wherein the inter-phase delay is between 0 μs and 4 μs.

18. The method of claim 12 , wherein the pulse train of energy include biphasic pulses.

19. The method of claim 12 , wherein the inter-phase delay, the inter-pulse delay, and the pulse width are constant over the duration of the pulse train of energy.

20. The method of claim 12 , wherein the pulse train of energy includes at least 60 pulses.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2023
From: STEWART, MARK T.; FRAASCH, STEVEN J.
To: MEDTRONIC, INC.
Reel/Frame 063871/0562 →
Continuity (4)
Continuation 16707260 · Dec 9, 2019
Continuation 15228406 · Aug 4, 2016
Provisional Application 62201622 · Aug 6, 2015
Related Publication 20230355303A1 · Nov 9, 2023
Cited By (4)
US 12,279,801 US 12,426,933 US 12,446,943 US 12,653,597